HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bork, R. W. Articles by Guengerich, F. P. Search for Related Content PubMed PubMed Citation Articles by Bork, R. W. Articles by Guengerich, F. P. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 264, Issue 2, 910-919, 01, 1989

Characterization of mRNA species related to human liver cytochrome P- 450 nifedipine oxidase and the regulation of catalytic activity

RW Bork, T Muto, PH Beaune, PK Srivastava, RS Lloyd and FP Guengerich
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.

P-450NF is the major enzyme in human liver involved in the metabolism of the calcium-channel blocker nifedipine. By screening a bacteriophage lambda gt11 expression library, a cDNA clone designated NF 10 with an insert length of 2.8 kilobases (kb) was isolated. This clone was sequenced and found to be highly similar in its overlapping section with sequences of two other cDNA clones previously isolated from the same expression library, NF 25 (Beaune, P. H., Umbenhauer, D. R., Bork, R. W., Lloyd, R. S., and Guengerich, F. P. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 8064-8068) and HLp (Molowa, D. T., Schuetz, E. G., Wrighton, S. A., Watkins, P. B., Kremers, P., Mendez-Picon, G., Parker, G. A., and Guzelian, P. S. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 5311-5315). However, clone NF 10 had an extra 814 or 813 bases of 3'- noncoding sequence relative to NF 25 or HLp, respectively, and this additional sequence contained a second consensus polyadenylation signal. Specific oligonucleotides were synthesized to differentiate between these three clones at the mRNA level. Oligonucleotides specific to the protein coding region of each clone were found to hybridize to mRNAs of 2.2 and 3.0 kb in size at a ratio of approximately 10:1. The major species of hybridizable mRNA was specific to clone NF 25, and levels of this mRNA could be correlated with levels of immunochemically detectable P-450NF and nifedipine oxidase activity in individual human liver samples. In addition, an oligonucleotide specific to the 3'- noncoding region of clone NF 10 hybridized only with the 3.0-kb mRNA. We conclude that alternative use of the second polyadenylation signal present in clone NF 10 results in production of the 3.0-kb mRNA species and that a pretranslational control mechanism is primarily involved in the regulation of nifedipine oxidase activity.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Lichti-Kaiser and J. L. Staudinger The Traditional Chinese Herbal Remedy Tian Xian Activates Pregnane X Receptor and Induces CYP3A Gene Expression in Hepatocytes Drug Metab. Dispos., August 1, 2008; 36(8): 1538 - 1545. [Abstract] [Full Text] [PDF]

				W. Chu, A. Fyles, E. M. Sellers, D. R. McCready, J. Murphy, T. Pal, and S. A. Narod Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use Carcinogenesis, October 1, 2007; 28(10): 2139 - 2142. [Abstract] [Full Text] [PDF]

				N. Torimoto, I. Ishii, K.-I. Toyama, M. Hata, K. Tanaka, H. Shimomura, H. Nakamura, N. Ariyoshi, S. Ohmori, and M. Kitada Helices F-G Are Important for the Substrate Specificities of CYP3A7 Drug Metab. Dispos., March 1, 2007; 35(3): 484 - 492. [Abstract] [Full Text] [PDF]

				A. Asghar, J. C. Gorski, B. Haehner-Daniels, and S. D. Hall Induction of Multidrug Resistance-1 and Cytochrome P450 mRNAs in Human Mononuclear Cells by Rifampin Drug Metab. Dispos., January 1, 2002; 30(1): 20 - 26. [Abstract] [Full Text] [PDF]

				S. A. Cavalli, M. H. Hirata, and R. D.C. Hirata Detection of MboII Polymorphism at the 5' Promoter Region of CYP3A4, Clin. Chem., February 1, 2001; 47(2): 348 - 351. [Full Text] [PDF]

				H. Echizen, M. Tanizaki, J. Tatsuno, K. Chiba, T. Berwick, M. Tani, F. J. Gonzalez, and T. Ishizaki Identification of CYP3A4 as the Enzyme Involved in the Mono-N-Dealkylation of Disopyramide Enantiomers in Humans Drug Metab. Dispos., August 1, 2000; 28(8): 937 - 944. [Abstract] [Full Text]

				T. Saito, Y. Takahashi, H. Hashimoto, and T. Kamataki Novel Transcriptional Regulation of the Human CYP3A7 Gene by Sp1 and Sp3 through Nuclear Factor kappa B-like Element J. Biol. Chem., October 5, 2001; 276(41): 38010 - 38022. [Abstract] [Full Text] [PDF]